Measuring the macro- and microvascular responses to LPS and exenatide
Phase 1
Recruiting
- Conditions
- Cardiovascular and metabolic diseases
- Registration Number
- 2024-519014-31-00
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing, recruiting
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre for Human Drug Research
🇳🇱Leiden, Netherlands
Centre for Human Drug Research🇳🇱Leiden, NetherlandsMatthijs MoerlandSite contact0715246400clintrials@chdr.nl